69 related articles for article (PubMed ID: 9048492)
1. P-glycoprotein as an intermediate end point of drug resistance to neoadjuvant chemotherapy in locally advanced gastric cancer.
Chung HC; Gong SJ; Yoo NC; Noh SH; Kim JH; Roh JK; Min JS; Kim BS; Lee KB
Yonsei Med J; 1996 Dec; 37(6):397-404. PubMed ID: 9048492
[TBL] [Abstract][Full Text] [Related]
2. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Choi J; Lim H; Nam DK; Kim HS; Cho DY; Yi JW; Kim HC; Cho YK; Kim MW; Joo HJ; Lee KB; Kim KB
Br J Cancer; 2001 Jan; 84(2):186-92. PubMed ID: 11161374
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of P-glycoprotein expression and multidrug resistance assessed by in vitro thymidine incorporation assay in patients with gastric carcinoma].
Fujii H; Tanigawa N; Muraoka R; Masuda Y; Shimomatsuya T; Kato Y; Aotake T; Kitaoka A; Yamakawa M; Tanaka T
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2763-70. PubMed ID: 7993112
[TBL] [Abstract][Full Text] [Related]
4. Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer.
Yu P; Du Y; Yang L; Fan S; Wu J; Zheng S
Int J Clin Exp Pathol; 2014; 7(11):7945-50. PubMed ID: 25550836
[TBL] [Abstract][Full Text] [Related]
5. Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer.
Xu HW; Xu L; Hao JH; Qin CY; Liu H
J Int Med Res; 2010; 38(1):34-42. PubMed ID: 20233511
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer.
Shin SJ; Jeung HC; Ahn JB; Choi HJ; Cho BC; Rha SY; Yoo NC; Roh JK; Chung HC
Cancer Chemother Pharmacol; 2008 Jan; 61(1):157-65. PubMed ID: 17426971
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
Kim R; Osaki A; Tanabe K; Toge T
Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
[TBL] [Abstract][Full Text] [Related]
10. Significance of MDR-related proteins in the postoperative individualized chemotherapy of gastric cancer.
Yu P; Cheng X; Du Y; Yang L; Huang L
J Cancer Res Ther; 2015; 11(1):46-50. PubMed ID: 25879335
[TBL] [Abstract][Full Text] [Related]
11. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein expression in non-Hodgkin's lymphomas of human immunodeficiency virus infected patients.
Tanaka PY; Calore EE
Pathol Res Pract; 2007; 203(1):1-7. PubMed ID: 17157997
[TBL] [Abstract][Full Text] [Related]
14. [Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis].
Yu PF; Guo JM; Xu Q; Ying JE; Wang XJ; Cheng XD; Wang XB; Yu CD
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):289-93. PubMed ID: 20422488
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.
Triller N; Korosec P; Kern I; Kosnik M; Debeljak A
Lung Cancer; 2006 Nov; 54(2):235-40. PubMed ID: 16934363
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer.
Chung HC; Rha SY; Kim JH; Roh JK; Min JS; Lee KS; Kim BS; Lee KB
Breast Cancer Res Treat; 1997 Jan; 42(1):65-72. PubMed ID: 9116319
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Vishnukumar S; Umamaheswaran G; Anichavezhi D; Indumathy S; Adithan C; Srinivasan K; Kadambari D
Indian J Cancer; 2013; 50(3):195-9. PubMed ID: 24061458
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
20. The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy.
Monden N; Abe S; Hishikawa Y; Yoshimura H; Kinugasa S; Dhar DK; Tachibana M; Nagasue N
Int J Surg Investig; 1999; 1(1):3-10. PubMed ID: 11817335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
